Minerva Neurosciences Net Tangible Assets

Minerva Neurosciences (NERV) currently reports a net tangible assets of $-250M as of March 2026. That compares with $-29M in the prior-year period — down 771.4% year over year. Use the charts on this page to explore Minerva Neurosciences's net tangible assets history and peer comparisons.

Minerva Neurosciences's net tangible assets decreased from $-29M to $-250M — a 771.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Minerva Neurosciences reported $-250M in net tangible assets as of March 2026. That compares with $-29M in the prior-year period — down 771.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Minerva Neurosciences, and consider following NERV for alerts when major investors trade the stock.

Minerva Neurosciences is classified in the Healthcare sector. On net tangible assets, it currently shows $-250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NERV with unrelated industries.